Literature DB >> 6724693

Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans.

B J MacKay, L Denepitiya, V J Iacono, S B Krost, J J Pollock.   

Abstract

Growth inhibition and cell viability assays demonstrate that the histidine-rich polypeptides isolated from human parotid saliva are bacteriostatic and bactericidal for strains of Streptococcus mutans belonging to the serotype b and c classifications. Both inhibition of growth and cell division are enhanced by preincubation of bacteria with these polypeptides in low-ionic-strength buffers of acidic and neutral pH before dilution into enriched growth media. With prior exposure at pH 6.8, inhibition by these polypeptides of the serotype c strains, S. mutans GS5 and SB, as well as the serotype b strain, S. mutans BHT, is reversible over time under the experimental conditions selected. With similar exposure at pH 5.2, however, irreversible damage is manifested by complete inhibition of both growth and cell viability. At concentrations of 250 micrograms of the mixture of histidine-rich polypeptides per 5 X 10(5) bacterial cells per ml in the acidic preincubation buffer, bacterial lethality is maintained for a period of 48 h in the enriched growth media. At a 50-micrograms/ml concentration of these salivary agents, approximately 80% killing of S. mutans SB is noted after a 24-h incubation; however, surviving bacteria multiply and reach turbidities of untreated control cells when examined at the 48-h growth point. Similarly, hen egg white lysozyme is also found to be bactericidal for these microorganisms when preincubation is carried out under acidic conditions. However, in contrast to the histidine-rich polypeptides, lysozyme under these experimental conditions does not inhibit growth of S. mutans SB at neutral pH, although it does inhibit growth of both S. mutans BHT and S. mutans GS5 at this pH. Preexposure of S. mutans SB to the peptides in buffer at ionic strengths of 0.025 to 0.125, followed by either viability assays under nongrowing conditions or growth inhibition studies, suggests that there is very little effect of ionic strength on the antibacterial function of these peptides. In contrast to the inhibition of viability noted under growing conditions, lower concentrations of the histidine-rich polypeptides were required to elicit immediate cell death under nongrowing conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724693      PMCID: PMC263672          DOI: 10.1128/iai.44.3.695-701.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Damage and recovery in streptococci.

Authors:  J Payne
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1978

2.  BACTERIOLOGY OF DENTAL CARIES.

Authors:  R J GIBBONS
Journal:  J Dent Res       Date:  1964 Nov-Dec       Impact factor: 6.116

3.  The agglutination and growth inhibition of bacteria by lysine polypeptides.

Authors:  W C BURGER; M A STAHMANN
Journal:  Arch Biochem Biophys       Date:  1952-07       Impact factor: 4.013

4.  Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria.

Authors:  E W Goodell; R Lopez; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

5.  Growth of several cariogenic strains of oral streptococci in a chemically defined medium.

Authors:  B Terleckyj; N P Willett; G D Shockman
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

6.  Murein hydrolases in the envelope of Escherichia coli. Properties in situ and solubilization from the envelope.

Authors:  R Hartmann; S B Bock-Hennig; U Schwarz
Journal:  Eur J Biochem       Date:  1974-01-03

7.  Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells.

Authors:  I Olsson; P Venge
Journal:  Blood       Date:  1974-08       Impact factor: 22.113

8.  Bactericidal activity of fractionated granule contents from human polymorphonuclear leukocytes.

Authors:  M C Modrzakowski; M H Cooney; L E Martin; J K Spitznagel
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

9.  Mechanisms for the microbicidal activity of cationic proteins of human granulocytes.

Authors:  H Odeberg; I Olsson
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

10.  Antibacterial effects associated with changes in bacterial cytology produced by cationic polypeptides.

Authors:  J K SPITZNAGEL
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  36 in total

1.  Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5.

Authors:  D M Rothstein; P Spacciapoli; L T Tran; T Xu; F D Roberts; M Dalla Serra; D K Buxton; F G Oppenheim; P Friden
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.

Authors:  H Gusman; J Travis; E J Helmerhorst; J Potempa; R F Troxler; F G Oppenheim
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  A new small molecule inhibits Streptococcus mutans biofilms in vitro and in vivo.

Authors:  W Pan; M Fan; H Wu; C Melander; C Liu
Journal:  J Appl Microbiol       Date:  2015-09-24       Impact factor: 3.772

4.  Poly L-histidine. A potent stimulator of superoxide generation in human blood leukocytes.

Authors:  I Ginsburg; R Borinski; M Sadovnic; Y Eilam; K Rainsford
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

5.  Proteome of human minor salivary gland secretion.

Authors:  W L Siqueira; E Salih; D L Wan; E J Helmerhorst; F G Oppenheim
Journal:  J Dent Res       Date:  2008-05       Impact factor: 6.116

6.  Streptococcus sanguis surface antigens and their interactions with saliva.

Authors:  R J Lamont; B Rosan; G M Murphy; C T Baker
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 7.  Intracellular Targeting Mechanisms by Antimicrobial Peptides.

Authors:  Cheng-Foh Le; Chee-Mun Fang; Shamala Devi Sekaran
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 8.  Ecological Therapeutic Opportunities for Oral Diseases.

Authors:  Anilei Hoare; Philip D Marsh; Patricia I Diaz
Journal:  Microbiol Spectr       Date:  2017-08

9.  Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans.

Authors:  J J Pollock; L Denepitiya; B J MacKay; V J Iacono
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

10.  Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization.

Authors:  Alice L Den Hertog; Harro W Wong Fong Sang; Ruud Kraayenhof; Jan G M Bolscher; Wim Van't Hof; Enno C I Veerman; Arie V Nieuw Amerongen
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.